Hemosol CEO takes sick leave at critical time for drug firm

Article Abstract:

Hemosol Inc.'s chief executive, John Kennedy, has taken a medical leave of absence from his post. The 45-year old Kennedy will continue his treatment for cancer. However, his absence comes at a critical period for Hemosol.

Leave of Absence, Health aspects, Diseases, Leaves of absence, Hemosol Inc., Kennedy, John

---

Lapointe leads ConjuChem comeback

Article Abstract:

The Montreal based drug Development company, ConjuChem Inc's director, Jacques Lapointe's decision to take up the post of director in the company, his future plans for the company and its management is discussed.

Strategy & planning, Management dynamics, Pharmaceutical preparations, Management, Planning, Company business management, Company business planning, Lapointe, Jacques, ConjuChem Inc.

---

Biovail CEO got top executive pay package

Article Abstract:

Biovail Corp.'s chief executive, Eugene Melnyk, received 66.3 million Canadian dollars in salary and stock options profits in the 2002 year. Melnyk led all Canadian executives in terms of their pay packages.

Personnel administration, Compensation and benefits, Biovail Corp., Melnyk, Eugene

Similar abstracts:

• Abstracts: Tories rile auto firms with call for mandatory fuel efficiency. MPs mull not signing bank report
• Abstracts: The Shiite shock wave. Cash from chaos
• Abstracts: Hefty surplus seen up Ottawa's sleeve. Dodge forecasts brighter future. Ottawa, Ontario rev up interest in auto industry
• Abstracts: Record oil prices spark warning of potential for bubble: 'This market is about fear'. Consumers at the wheel of gas price fluctuations: wild cost swings at the pumps are a sore spot for Canadians
• Abstracts: Cinram stakes future on DVDs: Product popularity and U.S. interest fuel firm's growth. DVDs a hit in Canada, especially among Gen Y

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.